Switch to:
More From Other Websites
PBM EnvisionRx chooses Gilead hepatitis C drugs for its formulary Jan 26 2015
Gilead Sciences: Time to Worry About a Tough 2015? Jan 26 2015
Gilead to Allow Drug Makers to Produce Hepatitis C Treatment Jan 26 2015
Gilead Expands Generic Sovaldi Pact to Add Investigational Pill Jan 26 2015
2:21 am Gilead Sciences expands Hepatitis C generic licensing agreements to include investigational... Jan 26 2015
Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic... Jan 26 2015
Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic... Jan 26 2015
Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic... Jan 26 2015
Want To Control Drug Prices? Reject Price Controls Jan 26 2015
German insurers win discounts on Gilead's Sovaldi Jan 24 2015
German insurers win discounts on Gilead's Sovaldi Jan 24 2015
The Zacks Analyst Blog Highlights: AbbVie, Gilead and Celgene - Press Releases Jan 22 2015
Deutsche Bank Comments On Concerns Over Consensus Estimates For AbbVie And Gilead Sciences Jan 21 2015
Gilead's John Martin Named Morningstar CEO of 2014 Jan 21 2015
DMG MORI SEIKI AKTIENGESELLSCHAFT and DMG MORI SEIKI CO., LTD. to enter into Cooperation Agreement Jan 21 2015
Morningstar Names John Martin of Gilead Sciences as its 2014 CEO of the Year Jan 21 2015
Healthcare ETFs in Focus on Mixed JNJ Results - ETF News And Commentary Jan 21 2015
Morningstar's 2014 CEO of the Year Jan 21 2015
Podcast: What to Expect From the 4th Quarter Earnings Season Jan 21 2015
Can Gilead Sciences Beat Hep-C Estimates? Jan 20 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK